Shuttle Pharmaceuticals delays shareholder special meeting to Sept. 9 from Sept. 3

• Shuttle Pharmaceuticals postponed its special shareholder meeting to Sept. 9, 2026 from Sept. 3, 2026.
• Delay aims to extend proxy solicitation, give investors more time to review proposals, support broader participation.
• Proxy votes must be received by 11:59 p.m. ET on Sept. 8, 2026 to be counted.
• Previously submitted valid proxies remain in effect unless changed or revoked before voting at the reconvened meeting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-041213), on September 02, 2026, and is solely responsible for the information contained therein.